Taken together, these data further indicated that EIE-2, by directly targeting Syk, resulted in an upregulation of the PKCθ/mTOR ratio at the transcription level in Jurkat cells under conditions that mimic the active phase of RA, as induced by TNF-α. Here, SYK is linked to rheumatoid arthritis.